Outcome of selected breast cancer patients with micrometastasis or isolated tumor cells in sentinel node biopsy and no completion axillary lymph node dissection

Journal of Surgical Oncology

Volumn 102, Issue 3, 2010, Pages 215-219

  Meretoja, Tuomo J ^a   Vironen, Jaana H ^a   Heikkilä, Päivi S ^a   Leidenius, Marjut H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Axillary lymph node dissection; Axillary recurrence; Breast cancer; Sentinel node biopsy

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MICROMETASTASIS; PATIENT SELECTION; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 77956378093     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21608     Document Type: Article

References (30)

1. Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: A metaanalysis. Cancer 2006;106:4-16. (Pubitemid 43033320)
2. Grube B, Giuliano A: Observation of the breast cancer patient with a tumor-positive sentinel node: Implications of the ACOSOG Z0011 trial. Semin Surg Oncol 2001;20:230-237. (Pubitemid 32830834)
3. Park J, Fey J, Naik A, et al.: A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 2007;245:462-468. (Pubitemid 46673143)
4. Barranger E, Coutant C, Flahault A, et al.: An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 2005;91:113-119. (Pubitemid 40684923)
5. Van Zee K, Manasseh D, Bevilacqua J, et al.: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003;10:1140-1151. (Pubitemid 40486808)
6. Pal A, Provenzano E, Duffy S, et al.: A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 2008;95:302-309.
7. Kohrt H, Olshen R, Bermas H, et al.: New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 2008;8:66. (Pubitemid 351566658)
8. Houvenaeghel G, Nos C, Giard S, et al.: A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol 2009;35:690-695.
9. Unal B, Gur A, Kayiran O, et al.: Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: The importance of scoring system. Int J Clin Pract 2008;62:1785-1791.
10. Guenther J, Hansen N, DiFronzo L, et al.: Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003;138:52-56. (Pubitemid 36055648)
11. Fant J, Grant M, Knox S, et al.: Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003;10:126-130. (Pubitemid 40485931)
12. Jeruss J, Winchester D, Sener S, et al.: Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 2005;12:34-40. (Pubitemid 40486639)
13. Naik A, Fey J, Gemignani M, et al.: The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: A follow-up study of 4008 procedures. Ann Surg 2004;240:462-468; discussion 468-471.
14. Hwang R, Gonzalez-Angulo A, Yi M, et al.: Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 2007;110:723-730. (Pubitemid 47257646)
15. Cox C, Kiluk J, Riker A, et al.: Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 2008;206:261-268.
16. Zakaria S, Pantvaidya G, Reynolds C, et al.: Sentinel node positive breast cancer patients who do not undergo axillary dissection: Are they different? Surgery 2008;143:641-647.
17. Leidenius MH, Krogerus LA, Toivonen TS, et al.: Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours. Eur J Surg Oncol 2005;31:364-368. (Pubitemid 40521300)
18. Cserni G, Gregori D, Merletti F, et al.: Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 2004;91:1245-1252. (Pubitemid 39331448)
19. Viale G, Maiorano E, Pruneri G, et al.: Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005;241:319-325.
20. Christiansen P, Friis E, Balslev E, et al.: Sentinel node biopsy in breast cancer: Five years experience from Denmark. Acta Oncol 2008;47:561-568. (Pubitemid 351878457)
21. Leidenius MH, Vironen JH, Riihela MS, et al.: The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases. Eur J Surg Oncol 2005;31:13-18. (Pubitemid 40103919)
22. van Deurzen C, de Boer M, Monninkhof E, et al.: Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 2008;100:1574-1580.
23. Houvenaeghel G, Nos C, Mignotte H, et al.: Micrometastases in sentinel lymph node in a multicentric study: Predictive factors of nonsentinel lymph node involvement - Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer. J Clin Oncol 2006;24:1814-1822. (Pubitemid 46638978)
24. Leidenius M, Vironen J, Heikkilä P, et al.: Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol 2010;17(1):254-262.
25. Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003.
26. Sobin LH, Wittekind CH, editors. TNM classification of malignant tumours. New York: Wiley-Liss; 2002.
27. Joensuu H, Kellokumpu-Lehtinen P, Bono P, et al.: Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. N Engl J Med 2006;354:809-820. (Pubitemid 43290919)
28. van der Ploeg IM, Nieweg OE, van Rijk MC, et al.: Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008;34(12):1277-1284.
29. Leikola JP, Toivonen TS, Krogerus LA, et al.: Rapid immunohistochemistry enhances the intraoperative diagnosis of sentinel lymph node metastases in invasive lobular breast carcinoma. Cancer 2005;104:14-19.
30. Orr R: The impact of prophylactic axillary node dissection on breast cancer survival - A Bayesian meta-analysis. Ann Surg Oncol 6:109-116.